Kona Medical Inc., a Bellevue, Washington, and Menlo Park, Calif.-based developer of ultrasound technology to treat the nerves leading to and from the kidney, has added $10m in equity and debt financing to close its Series C round.
This latest transactions bring the total amount raised to $40m (read here about the first portion of the round).
Backers include Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western Technology Investments, and BioStar Ventures. Silicon Valley Bank provided the debt facility.
Founded by CEO Michael Gertner, MD, The company has developed The Kona Surround SoundTM system. which uses ultrasound, delivered from outside the body, to treat the nerves leading to and from the kidney. Renal denervation has been shown in clinical studies to lead to significant and lasting reductions in high blood pressure.
Kona Medical has 25 employees.